Ingestion of aristolochic acid (AA) can cause AA nephropathy (AAN), in which excessive death of tubular epithelial cells (TECs) characterize the acute phase. AA forms adducts with DNA, which may lead to TEC apoptosis via p53-mediated signaling. We tested this hypothesis both by studying p53-deficient mice and by blocking p53 in TECs with its inhibitor pifithrin-␣. AA induced acute AAN in wild-type mice, resulting in massive apoptotic and necrotic TEC death and acute renal failure; p53 deficiency or pharmacologic inhibition attenuated this injury. In vitro, AA induced apoptotic and necrotic death of TEC in a time-and dosage-dependent manner, with apoptosis marked by a 10-fold increase in cleaved caspase-3 and terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine nick-end labeling-positive/Annexin V-positive propidium iodide-negative TECs (all P Ͻ 0.001). AA induced dephosphorylation of STAT3 and the subsequent activation of p53 and TEC apoptosis. In contrast, overexpression of STAT3, p53 inhibition, or p53 knockdown with small interfering RNA all attenuated AA-induced TEC apoptosis. Taken together, these results suggest that AA induces TEC death via apoptosis by dephosphorylation of STAT3 and posttranslational activation of p53, supporting the hypothesis that p53 promotes renal injury in acute AAN.
Chinese herb nephropathy was first reported in Belgium in patients with prolonged intake of Chinese herbs during a slimming regimen and is recognized as one of the most severe complications caused by traditional Chinese medicine. [1] [2] [3] It is now clear that the major substance that causes Chinese herb nephropathy is the plant nephrotoxin aristolochic acid and its metabolism products. 4 -6 Thus, the term aristolochic acid nephropathy (AAN), instead of Chinese herbal nephropathy, is used today. 7, 8 AAN has emerged as an important cause of drugassociated renal failure worldwide. 9 Patients with AAN exhibit a rapidly progressive renal deterioration, resulting in acute renal failure that could lead to ESRD. [1] [2] [3] 10, 11 A similar clinical course was observed in experimental animals treated with AA. 12, 13 Pathologically, chronic AAN is characterized by extensive interstitial fibrosis with atrophy and loss of renal tubules. 1-3,10 -13 The lesions of chronic AAN are mainly in the cortex involving proximal tubular epithelial cells (TECs) 10 -13 ; glomeruli are relatively spared with minimal inflammation. 9 -12 In contrast, progressive TEC death occurs early in the clinical course with an absence of renal fibro- Ratio between cleaved caspase-3 and GAPDH measured from Western blots. Data are means Ϯ SEM for groups of six animals. *P Ͻ 0.05, ***P Ͻ 0.001 versus normal mice treated with saline; # P Ͻ 0.05, ## P Ͻ 0.01 versus p53 WT mice with acute AAN. Magnification, ϫ400.
(J) Measurement of creatinine clearance. Data are means Ϯ SEM for groups of six animals. **P Ͻ 0.01, ***P Ͻ 0.001 versus normal mice treated with saline; # P Ͻ 0.05, ### P Ͻ 0.001 versus p53 WT mice with acute AAN. Sections are stained with periodic acidSchiff. Magnifications: ϫ200 in A through D; ϫ400 in E through F. sis and inflammation in experimental models and patients with acute AAN. 10, 14, 15 Although apoptosis is an important pathologic feature in in vivo and in vitro studies of acute AAN, 16 -18 the underlying mechanisms remain unclear.
In considering the genotoxic effect of AA with the formation of AA-DNA adducts and the importance of the p53 signaling pathway in DNA damage and cell apoptosis, 19 -21 we hypothesized that TEC apoptosis in acute AAN is depen- BASIC RESEARCH www.jasn.org dent on p53 signaling. We investigated this by inducing acute AAN in p53 knockout (KO) and p53 wild-type (WT) mice and by blocking the p53 activities with a pharmacologic inhibitor. We further studied the toxicity of AA on TEC apoptosis by examining a panel of apoptotic biomarkers. The mechanism that AA induced TEC apoptosis by activating p53 via a STAT3-dependent posttranslational modification was identified.
RESULTS

Mice Lacking the p53 Gene Are
Protected from the Development of Acute AAN
We first tested the hypothesis that AA induced acute AAN via a p53-dependent mechanism by examining acute AAN induced in p53 WT and p53 KO mice. Histologically, compared with saline control mice, p53 WT mice developed severe acute AAN with focal and severe "shrinkage necrosis" and coagulative necrosis in TECs in the renal cortex at day 4 after AA injection, affecting up to 25 to 30% of cortical tubules (Figure 1) . Most of the nonviable TECs exhibited typical apoptotic cell morphology, including cytoplasmic and nuclear condensation, fragmentation, and vacuolization ( Figure 1 , C and E). The TECs were detached from the tubular basement leading to naked basement membrane, a typical pathologic feature of AAN. The p53 WT mice treated with AA developed moderate to severe renal impairment with a threefold increase in urinary protein excretion ( Figure 1H ), a two-fold increase in serum creatinine ( Figure 1I ), and a two-fold reduction of creatinine clearance ( Figure 1J ). In contrast, the KO mice lacking p53 were resistant to the development of AA-induced acute AAN with normal levels of urinary protein excretion, serum creatinine, and creatinine clearance. Only a small proportion of tubules demonstrated coagulative necrosis with a swollen, rather than condensed, necrotic morphology, but naked basement membrane change was not observed ( Figure 2Aiv ). Semiquantitative analysis of TUNEL ϩ cell population suggested that, in addition to necrosis, apoptosis contributed to acute tubular cell death in acute AAN ( Figure 2C ). The importance of a p53-dependent apoptotic pathway in acute AAN was further suggested by another biomarker, cleaved caspase-3. The renal expression of cleaved caspase-3 was increased in p53 WT mice treated with AA, but such increase was attenuated in p53 KO mice under an identical experimental condition ( Figure 2 , B and D).
We next explored whether a p53 inhibitor, pifithrin-␣, exerted any therapeutic potential in acute AAN. Pifithrin-␣ at a dosage of 4.4 mg/kg per d was administered intraperitoneally for 3 d to p53 WT mice pretreated with AA. p53 blockade reduced TEC death ( Figure 3 , A through E) and the rise of serum creatinine ( Figure 3G ) with no significant attenuation of proteinuria ( Figure 3F ) or improvement of creatinine clearance ( Figure 3H ). Correspondingly, the histology and biomarker for apoptosis in AA-induced AAN were improved after pifithrin-␣ treatment (Figure 4) .
In Vitro Study of Cultured TECs Exposed to AA
To understand better the signaling pathway mediating the p53-dependent apoptosis in acute AAN, we performed in vitro studies on a normal rat TEC line (NRK52E). We confirmed that AA caused TEC necrosis at 24 h in a dosage-dependent manner (Figure 5A ). This was also associated with apoptosis, shown by a 10-fold increase in both TUNEL ϩ and Annexin V ϩ propidium iodide-negative (PI Ϫ ) TECs ( Figure 5 , B through E) and in cleaved caspase-3 ( Figure 6 ). Notably, higher dosages of AA (Ͼ10 g/ml) Figure 5H ). Nonetheless, apoptosis remained the most important mechanism of TEC death in acute AAN because this occurred even at a dosage with undetectable cytotoxicity (Ͻ5 g/ml).
The therapeutic effect of p53 blockade in AA-induced TEC apoptosis was confirmed in vitro with a p53 pharmacologic inhibitor, pifithrin-␣, and p53 small interfering RNA (siRNA). The p53 inhibitor (20 M) inhibited AAinduced (5 g/ml) TEC death ( Figure 7A ) and apoptosis as determined by TUNEL ϩ TECs (60% reduced; Figure 7 , B and D), Annexin V ϩ PI Ϫ TECs (50% reduced; Figure 7 , C and E), and cleaved caspase-3 (40% reduced; Figure 7 , F and G). The addition of p53 siRNA (25 nM) but not a control siRNA (25 nM) reduced p53 mRNA expression by Ͼ80% ( Figure 8A ). This was associated with the inhibition of AAinduced (5 g/ml) TEC death detected by Trypan blue exclusion ( Figure 8B ) and apoptosis detected by cleaved caspase-3 ( Figure 8C ) and Annexin V ϩ PI Ϫ TECs ( Figure 8D ).
AA Activates p53 by Posttranslational Modification
We next investigated the mechanism by which AA activated the p53 pathway during TEC apoptosis by examining p53 mRNA expression transcriptionally and posttranslational modification by phosphorylation of p53 protein. Real-time PCR showed that the addition of AA did not significantly induce p53 mRNA expression in a time-and dosage-dependent manner ( Figure 9 , A and B); however, Western blot analysis revealed that AA was able to activate the p53 pathway posttranslationally by phosphorylation, because we detected high levels of phosphorylated p53 (Ser15) in a timeand dosage-dependent manner ( Figure 9 , C and D). This resulted in a 130-fold increase in the phosphorylated p53 at 24 h after stimulation by AA (5 g/ml; Figure 9C ) that was associated with an increase in total p53 protein in a timeand dosage-dependent manner ( Figure 9 , C and D).
To determine further the functional importance of phosphorylated p53 in AA-induced apoptosis, we examined whether blockade of p53 inhibited AA-induced TEC apoptosis in vitro and in vivo. Knockdown of p53 with the p53 siRNA resulted in a marked inhibition of AA-induced (5 g/ml) p53 protein phosphorylation (Ͼ80% reduced) and accumulation (60% reduced; Figure 9E ). In parallel, this was associated with a marked inhibition of TEC apoptosis in response to AA shown by measuring cleaved caspase-3 and Annexin V (Figure 8, C  and D) . The functional importance of phosphorylated p53 in AA-induced apoptosis was better documented in acute AAN induced in p53 WT and KO mice ( Figure 9F ).
AA Induces Phosphorylation of p53 via a STAT3-Dependent Mechanism
To explore further the upstream signaling mechanism by which AA activated the p53 pathway, we examined the activation of STAT3 by phosphorylation because phospho-STAT3 mediated the suppression of p53 function. 22 Addition of AA (5 g/ml) caused dephosphorylation of phospho-STAT3 (Tyr705), thereby reducing STAT3 protein expression in a time-and dosage-dependent manner (Figure 10 ). The functional role of phospho-STAT3 in protecting AA-mediated TEC apoptosis via the p53 pathway was further demonstrated by the finding that overexpression of STAT3 in TECs rescued AA-induced (5 g/ml) dephosphorylation of STAT3, thereby inhibiting AA-induced p53 phosphorylation and p53 protein accumulation and p53-mediated apoptosis demonstrated by cleaved caspase-3 and TUNEL ϩ TECs (Figure 11 ).
DISCUSSION
Emerging evidence shows that AA is a key mediator of AAN characterized by progressive TEC death and renal scarring that ultimately result in acute or chronic renal failure. 1-3,10 -13 In animals and humans with acute AAN, progressive TEC death with patchy necrosis, primarily affecting proximal TECs in the renal cortex, is the major pathologic feature. 3, 10, 11, 14, 15, 23 Increased apoptosis has been observed in AA-associated cancers 24 -26 and in cultured tubular cells exposed to AA. 19, 27, 28 A calcium-dependent mitochondria stress mechanism has been proposed. 17, 27, 28 In this study, we provide new evidence to support the role of p53 in AAinduced acute AAN by demonstrating that mice null for p53 are protected against the development of acute AAN. These animals exhibited reduced TEC death through apoptosis with less renal injury. Furthermore, pharmacologic blockade of p53 using a p53 inhibitor, pifithrin-␣, partially protected AAinduced acute AAN with reduced TEC apoptosis and blunt rise of serum creatinine. The inability of pifithrin-␣ to improve proteinuria and creatinine clearance in acute AAN may be related to the necrotic feature of AAN and also the specificity, dosage, and individual response to pifithrin-␣ treatment. Interestingly, p53 blockade with specific siRNA inhibited the AA-induced TEC apoptosis that further supported the pathogenic role for p53 in the development of acute AAN, similar to that of p53 in cisplatin-induced nephrotoxicity. 29 p53 is a tumor suppressor that induces growth arrest, senescence, and apoptosis in response to various cellular stresses, including exposure to DNA-damaging agents and hypoxia. 21 A stress signal is transmitted to the p53 protein by posttranslational modifications, including phosphorylation, acetylation, methylation, ubiquitination, and sumoylation. 28, 30, 31 Activation of the p53 BASIC RESEARCH www.jasn.org protein initiates downstream programs, including cell-cycle arrest, cellular senescence, and apoptosis. 28,30 -32 Phosphorylation of p53 enhances the p53 activity through stabilization of the p53 protein, thereby preventing p53 from degradation. 31 Once activated, p53 can induce apoptosis through a transcriptional-dependent or -independent mechanism. The latter acts through increased permeabilization of the mitochondrial outer membrane, which may account for AA-induced TEC apoptosis via the calcium-dependent mechanism. 17, 27, 28 AA is a genotoxic agent, as evidenced by the formation of AA-DNA adducts in TECs and urothelial cells in AAN. 14, 20 AA-related DNA adducts are detected as early as day 1, reach a steady state level at day 2, and remain almost unchanged up to 5 wk. 14 Although the potential impact of AA-DNA adducts on tubular damage in acute AAN is largely unknown, its genotoxic stress is able to activate p53 by posttranslational modifications. 32, 33 Hence, AA-DNA adducts formed in TECs exert the genotoxic stress, 14, 20 which may represent a mechanism by which AA induces p53 phosphorylation as shown in this study.
In this study, we had found that TEC apoptosis induced by AA is mediated through the p53 pathway by posttranslational modification via a STAT3-dependent mechanism. We also demonstrated that AA is capable of inducing dephosphorylation of phospho-STAT3 in TECs, which resulted in a marked increase of phosphorylation of p53 (130-fold), increased accumulation of p53 protein, and enhanced TEC apoptosis. The functional importance of STAT3 in AA-induced p53-dependent TEC apoptosis was strongly supported by the finding that overexpressing STAT3 prevented AA-induced p53 phosphorylation and p53-dependent TEC apoptosis. This is similar to a previous finding that IL-24 induces apoptosis of chronic lymphocytic leukemia B cells through a mechanism of dephosphorylation of STAT3 and stabilization of p53 expression by phosphorylating p53 (Ser15). 22 In this study, AA induced TEC apoptosis by activating the p53 pathway via inactivation of the p53 repressor STAT3. Addition of AA also induces the dephosphorylation of STAT3, leading to stabilization of p53 by increasing p53 (Ser15) phosphorylation and protein accumulation. Hence, dephosphorylation of STAT3 may be an important mechanism by which AA activates the p53-dependent pathway to mediate TEC apoptosis. Because of the complexity of p53 stabilization and activation in various disease conditions, 22,29,30 -35 further studies to understand fully how AA activates p53 signaling pathways are warranted.
It should be pointed out that although apoptosis is a mechanism of AA-induced acute AAN, TEC necrosis also occurs in acute AAN; a small proportion of tubules with typical changes of coagulative necrosis, rather than shrinkage necrosis, is found in p53 KO mice, and addition of AA at a higher dosage (Ͼ10 g/ml) also causes significant cytotoxicity in TECs in vitro. We also recognize that TEC apoptosis induced by AA in both in vitro and in vivo settings is a dynamic process, and, hence, analysis of apoptosis at certain time points may underestimate the proportion of apoptotic cells. Furthermore, only a few TUNEL ϩ apoptotic cells are found in p53 KO mice with acute AAN despite that we have demonstrated an important role of p53 in AA-induced TEC apoptosis. These findings suggest other mechanisms independent of p53 may also participate in the process of apoptosis induced by AA.
CONCISE METHODS
Animal Model of Acute AAN
p53 KO mice were a gift from Prof. Lawrence A. Donehower (Baylor College of Medicine). 36 This p53 mutant mouse was bred on a C57BL/6-Tyrc background and tagged with a tyrosinase coat color minigene that makes mouse genotype distinguishable by their coat color. Acute AAN was induced in genetically identical littermates of p53 WT and KO mice (n ϭ 6, male, aged 8 to 12 wk) with AA at a dosage of 10 mg/kg per d in 200 l of saline injected intraperitoneally for 3 d. For examination of the therapeutic effect of blocking p53 on acute AAN, a p53 pharmacologic inhibitor, pifithrin-␣, at an optimal dosage of 4.4 mg/kg per d was dissolved in DMSO and injected intraperitoneally into a group of six male p53 WT mice at the same time with AA (10 mg/kg per d) for 3 d. The dosage used for this study was determined by dosage-dependent studies of acute AAN induced in p53 WT mice. Control animals received the same amount of AA but saline-containing DMSO. Groups of six mice were killed on day 4 after AA injection with or without pifithrin-␣ treatment. In addition, groups of six normal, agedmatched WT and KO mice receiving a daily intraperitoneal injection of saline served as negative controls. Urine and kidney tissues were collected for further investigations as detailed next. p53 KO mice suspected of tumor were excluded. The experimental procedures were approved by the committee on the use of live animals for teaching and research at the University of Hong Kong.
Measurements of Proteinuria and Renal Function
All mice were housed in metabolic cages for 16 h before and after AA injection on days 0 and 3. Urinary protein excretion was determined using Coomassie Blue method and expressed as mg against urinary creatinine (mg), whereas creatinine in serum and urine was detected by QuantiChrom Creatinine Assay Kit (BioAssay Systems, Hayward, CA) as based on the improved Jaffe method.
Histology
Kidney sections (3 m) from p53 WT and KO mice embedded in methyl Carnoy's fixed paraffin and stained with periodic acid-Schiff was examined. Tubular necrosis in the entire cortex and tubulointerstitium (a cross-section of the kidney) was determined using the Image J program (National Institutes of Health). Briefly, the cortical area with tubular necrosis was identified and outlined. Ten fields (ϫ10) of cortical tissues were scored, and the percentage of necrotic area in the examined renal cortex was then measured. Data were expressed as a percentage of cortical area examined.
Cell Culture
Normal rat kidney TEC line (NRK52E) was grown in DMEM/F12 (Hyclone, Logan, UT) in a 5% CO 2 atmosphere at 37°C, containing 5% FBS, 60 g/ml penicillin, and 100 g/ml streptomycin. AA sodium salt (mixture of AAI [65%] and AAII [27%]; Sigma-Aldrich, St. Louis, MO) in various dosages (0.00, 1.25, 2.50, 5.00, and 10.00 g/ml) was added to the culture for 24 h. For a time-dependent experiment, a dosage of AA at 5 g/ml was added to the culture for periods of 0, 3, 6, 12, and 24 h. For blocking the p53 activity pharmacologically, a p53 inhibitor, pifithrin-␣ (20 M; Calbiochem, Darmstadt, Germany), or DMSO as control was added to the culture 1 h before addition of AA (5 g/ml). Parallel blocking experiment was conducted by transfecting p53 siRNA (25 nM) or control siRNA (25 nM; Ambion, Austin, TX) into NRK52E using lipofectamine 2000 (Invitrogen, Carlsbad, CA) for 72 h before addition of AA (5 g/ml) for 24 h. At least three independent experiments were performed throughout the study. For determination of cell survival in response to AA, the p53 inhibitor, and the p53 siRNA, dead cells (identified by 0.4% Trypan blue [Sigma-Aldrich]) were counted at 24 h, and the cell death rate was expressed as percentage of Trypan blue-positive cells.
For investigation of the protective role of STAT3 in AA-induced TEC apoptosis via the p53-dependent mechanism, a stable TEC line (NRK52E) expressing WT STAT3 was established by transfecting cells with a STAT3 WT or a control empty plasmid (pcDNA3) with lipofectamine 2000 (Invitrogen). Cells stably ex- BASIC RESEARCH www.jasn.org pressing STAT3 were selected with addition of G418 at a dosage of 100 mg/ml and thereafter were maintained in G418 at 50 mg/ml. The STAT3 plasmid was a gift from Prof. Akihiko Yoshimura (Kyushu University, Japan). 37 Cytotoxicity Analysis with LDH Assay and MTT Assay NRK52E were seeded in 96-well plates for confluence. Then AA in various dosages (1.25, 2.5, 5.0, 10.0, and 20.0 g/ml) was added for 24 h. The supernatants were collected for cytotoxicity analysis by LDH (TOX-7 kit; Sigma-Aldrich) and MTT assay (celltiter 96 Nonradioactive Cell Proliferation Assay; Promega, Madison, WI) according to the manufacturers' instructions. The LDH release rate was calculated as a percentage of total LDH.
Western Blot Analysis
Proteins from cultured cells or renal tissues were extracted with RIPA lysis buffer and analyzed by Western blot as described previously. 38 Briefly, after blocking nonspecific binding, the membranes were incubated with primary antibodies against p53, STAT3, phospho-STAT3 (Tyr705; Santa Cruz Biotechnology, Santa Cruz, CA), phosphop53 (Ser15), cleaved-caspase-3 (Asp175; Cell Signaling, Beverly, MA), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Chemicon, Temecula, CA) overnight at 4°C. After extensive wash, the membranes were then incubated with IRDye 800 -conjugated secondary antibodies (Rockland, Gilbertsville, PA) for 1 h before detection with Odyssey Infrared Imaging System. Positive immunoreactive bands were quantified and normalized by GAPDH using the Image J program (National Institutes of Health).
FACS Assay with Annexin V/PI Staining
Cells under various experimental conditions were first harvested with PBS containing 0.25% trypsin and 2% EDTA before processing with Annexin V/PI staining kit (Roche Applied Science, Indianapolis, IN) according to the manufacturer's instructions and finally analyzed in Cytomics FC 500 Flow Cytometer (Beckman Coulter, Fullerton, CA) for apoptosis detection. Annexin V ϩ PI Ϫ cells were recorded as apoptotic cells.
TUNEL Staining for Apoptosis
NRK52E cells were cultured in eight-chamber glass slides under various experimental conditions as described already. After fixing with 4% paraformaldehyde for 1 h, slides were stained with TUNEL kit (in situ cell death detection kit, POD; Roche Applied Science) following the manufacturer's instructions. Positive cells were counted from 500 cells on each slide chamber and expressed as a percentage of total cells. For detection of apoptotic cells in mouse kidney tissues, 3-m tissue sections were stained with TUNEL kit. TUNEL ϩ cells were counted under high-power fields (ϫ400) by means of a 0.025-mm 2 graticule fitted in the eyepiece of the microscope and expressed as cells per mm 2 .
Real-Time PCR
RNA was collected from cells or renal tissues and purified by the RNeasy kit according to the manufacturer's instructions (Qiagen Inc., Valencia, CA). The cDNA was synthesized, and real-time PCR was run with the Opticon real-time PCR machine (MJ Research, Waltham, MA) as described previously. 38 The specificity of real-time PCR was confirmed by the melting-curve analysis. Housekeeping gene GAPDH was used as an internal standard. The primers used in this study are as follows: p53, forward 5Ј-ACATGACTGAGGTCGT-GAGA and reverse 5Ј-TTTCCTTCCACCCGGATAAG; GAPDH, forward 5Ј-CCTGGAGAAACCTGCCAAGTATGA and reverse 5Ј-TT-GAAGTCACAGGAGACAACCTGG.
Statistical Analysis
Data obtained from this study are expressed as means Ϯ SEM. Statistical analyses were performed using one-way ANOVA followed by the Newman-Keuls as post hoc tests from GraphPad Prism 4.0 (GraphPad Software, San Diego, CA). 
ACKNOWLEDGMENTS
